Chesnara bags £1.7bn MetLife UK closed life book in latest takeover
Chesnara agreed to acquire MetLife UK's closed-book life insurance business for £1.7bn in assets, subject to regulatory approval. The deal is expected to generate £90m in lifetime cashflows, with £45m added to Own Funds and Contractual Service Margin. Chesnara aims to strengthen its UK business and future cash generation. Analysts note the deal boosts long-term capital generation without significantly impacting Chesnara's acquisition firepower.
How this was made
The 30-second read
Why it matters
The deal adds £1.7bn of assets to Chesnara while stripping MetLife of its closed‑book UK portfolio, altering cash‑flow expectations for both parties.
Market read
The transaction is a material M&A event that could move MetLife's stock and signals continued consolidation in the UK life insurance market.
What to watch
Regulatory approval risk and integration costs for Chesnara may affect the deal's ultimate value.
Background
Chesnara, a private UK insurer, continues its acquisition spree, having previously bought HSBC Life (UK) and Scottish Widows Europe.
Ticker impact
MetLife's UK closed-book life business is being sold to Chesnara in a £1.7bn deal, impacting MetLife's asset base and future cash flows.
potential downward pressure as the market prices in the loss of assets and cash flow.
The transaction size is material and the impact on MetLife's balance sheet is clearly disclosed for the first time.
Market effects
UK life insurance consolidation may tighten competition and affect other insurers' market share.
UK insurance sector could see a shift in asset management dynamics.
MetLife's global investors will reassess exposure to UK life insurance assets.
Counterpoint
The divestiture could free capital for MetLife to pursue higher‑growth opportunities elsewhere.
Key entities
- CompanyChesnara
Private UK insurer acquiring MetLife UK's closed‑book business.
- CompanyMetLife
US‑listed insurer (ticker MET) selling its UK closed‑book life portfolio.
